Quantcast
Last updated on April 18, 2014 at 7:23 EDT

Latest OncoSec Medical Inc. Stories

2012-06-05 02:27:34

SAN DIEGO, June 5, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announced today that the Company has entered into an exclusive cGMP manufacturing agreement with VGXI Inc. (VGXI) for the production of interleukin-12 plasmid DNA (DNA IL-12). Financial terms of the agreement were not disclosed. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) Punit...

2012-05-29 02:26:09

SAN DIEGO, May 29, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, issued the following letter to Shareholders today: (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) Dear Shareholder: As we near the mid-point of 2012, OncoSec is successfully executing on its objectives for the year. I want to review the key developments so you can see why all...

2012-05-29 02:26:08

SAN DIEGO, May 29, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Punit Dhillon, President and CEO at OncoSec, will be presenting at BioFinance 2012 in Toronto, Canada, on Wednesday, May 30, 2012. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) BioFinance 2012St. Andrew's Club & Conference Centre150 King...

2012-05-10 02:30:52

SAN DIEGO, May 10, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Punit Dhillon, President and CEO at OncoSec, will be presenting at the VC in the OC investor conference on May 15, 2012. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) VC in the OCHyatt Regency Huntington Beach21500 Pacific Coast HighwayHuntington Beach, CA...

2012-04-23 02:27:35

SAN DIEGO, April 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe. The study demonstrated the therapy's ability to provide local tumor control and...

2012-04-10 02:26:03

SAN DIEGO, April 10, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Punit Dhillon, President and CEO, and Michael Cross, Ph.D., MBA have contributed an article for the April 2012 issue of Manufacturing Chemist reviewing current strategies for the treatment of solid tumors. In addition, a feature was written in the April 9, 2012...

2012-03-05 05:01:00

SAN DIEGO, March 5, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Punit Dhillon, President and CEO of OncoSec, will be presenting at the 32nd Annual Cowen Group Healthcare Conference March 5-7 in Boston, MA, and the 24th Annual ROTH Conference, March 11-14 in Newport Beach. In addition, the company's Phase II Merkel cell...

2012-02-24 05:01:00

SAN DIEGO, Feb. 24, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Punit Dhillon, President and CEO at OncoSec, will be presenting at the 10th Annual BioPartnering North America in Vancouver, Canada, February 26-28, 2012. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) 10th Annual BioPartnering North America...

2012-02-08 05:01:00

SAN DIEGO, Feb. 8, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Punit Dhillon, President and CEO at OncoSec, will be presenting at the 14th Annual BIO CEO & Investor Conference in New York, February 13-14, 2012. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) 14th Annual BIO CEO & Investors ConferenceThe...

2012-02-01 05:01:00

SAN DIEGO, Feb. 1, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Punit Dhillon, President and CEO, has written a front-page article for the February 2012 issue of Physicians News Digest outlining cutting-edge strategies for the treatment of solid tumors. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) The...